Mr. Ray Doyle:

No, I am not aware of any analysis that has been done since then. The drastic change in sales was in intramammary products, which are antibiotics. Supposedly up to 1 December we have the derogation and it is currently business as usual. From the HPRA point of view we are effectively dispensing POM products. However, from our point of view we are dispensing products we have been dispensing since 2007 in the manner we always have been which is de facto prescribing them because of the advice etc. we are giving them.

I might summarise where it is-----